Citizens Business Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.91M Sell
31,769
-643
-2% -$143K 1.13% 25
2025
Q4
$7.41M Buy
32,412
+116
+0.4% +$26.4K 1.22% 22
2025
Q3
$7.48M Buy
32,296
+851
+3% +$173K 1.25% 22
2025
Q2
$5.84M Buy
31,445
+650
+2% +$121K 1.13% 26
2025
Q1
$6.45M Buy
30,795
+7,534
+32% +$1.46M 1.4% 20
2024
Q4
$5.53M Sell
23,261
-8,518
-27% -$1.57M 1.03% 32
2024
Q3
$6.28M Sell
31,779
-765
-2% -$143K 1.27% 22
2024
Q2
$5.58M Buy
32,544
+447
+1% +$74K 1.18% 23
2024
Q1
$5.84M Sell
32,097
-489
-2% -$84.3K 1.22% 24
2023
Q4
$5.05M Sell
32,586
-2,740
-8% -$399K 1.11% 25
2023
Q3
$5.27M Sell
35,326
-1,406
-4% -$206K 1.24% 24
2023
Q2
$4.95M Buy
36,732
+1,165
+3% +$171K 1.1% 24
2023
Q1
$5.67M Sell
35,567
-1,407
-4% -$215K 1.31% 20
2022
Q4
$5.98M Sell
36,974
-90
-0.2% -$13.8K 1.37% 18
2022
Q3
$4.97M Sell
37,064
-28,736
-44% -$4.12M 1.21% 19
2022
Q2
$10.1M Buy
65,800
+162
+0.2% +$24.8K 1.43% 11
2022
Q1
$10.6M Sell
65,638
-5,886
-8% -$855K 1.29% 15
2021
Q4
$9.69M Sell
71,524
-434
-0.6% -$51.3K 1.19% 18
2021
Q3
$7.76M Sell
71,958
-82
-0.1% -$9.37K 1.03% 19
2021
Q2
$8.12M Buy
72,040
+226
+0.3% +$25.5K 1.07% 19
2021
Q1
$7.77M Buy
71,814
+10,848
+18% +$1.16M 1.09% 19
2020
Q4
$6.53M Sell
60,966
-903
-1% -$86.8K 0.96% 18
2020
Q3
$5.42M Buy
61,869
+7,421
+14% +$699K 0.92% 24
2020
Q2
$5.35M Buy
54,448
+9,317
+21% +$820K 0.94% 23
2020
Q1
$3.44M Buy
45,131
+755
+2% +$64.3K 0.71% 31
2019
Q4
$3.93M Sell
44,376
-1,131
-2% -$93.9K 0.65% 37
2019
Q3
$3.45M Sell
45,507
-636
-1% -$43.6K 0.57% 44
2019
Q2
$3.36M Sell
46,143
-827
-2% -$65K 0.56% 43
2019
Q1
$3.79M Sell
46,970
-13,883
-23% -$1.14M 0.65% 32
2018
Q4
$5.61M Sell
60,853
-865
-1% -$76.1K 1.08% 21
2018
Q3
$5.84M Sell
61,718
-960
-2% -$91K 0.98% 21
2018
Q2
$5.81M Sell
62,678
-1,008
-2% -$98.4K 1.01% 22
2018
Q1
$6.03M Buy
63,686
+41
+0.1% +$4.5K 1.06% 21
2017
Q4
$6.16M Sell
63,645
-391
-0.6% -$36.9K 1% 21
2017
Q3
$5.69M Sell
64,036
-3,177
-5% -$242K 0.95% 20
2017
Q2
$4.87M Buy
67,213
+30,681
+84% +$2.06M 0.81% 24
2017
Q1
$2.38M Sell
36,532
-3,700
-9% -$233K 0.4% 67
2016
Q4
$2.52M Sell
40,232
-9,496
-19% -$580K 0.45% 62
2016
Q3
$3.14M Sell
49,728
-1,751
-3% -$113K 0.58% 48
2016
Q2
$3.19M Sell
51,479
-1,900
-4% -$116K 0.6% 48
2016
Q1
$3.05M Buy
53,379
+400
+0.8% +$22.3K 0.57% 49
2015
Q4
$3.14M Sell
52,979
-5,150
-9% -$297K 0.61% 50
2015
Q3
$3.16M Sell
58,129
-224
-0.4% -$14.6K 0.6% 54
2015
Q2
$3.92M Sell
58,353
-566
-1% -$37K 0.68% 45
2015
Q1
$3.45M Buy
58,919
+4,597
+8% +$278K 0.61% 57
2014
Q4
$3.55M Sell
54,322
-5,070
-9% -$320K 0.64% 50
2014
Q3
$3.43M Sell
59,392
-709
-1% -$39.4K 0.66% 44
2014
Q2
$3.39M Buy
60,101
+5,550
+10% +$291K 0.65% 42
2014
Q1
$2.8M Buy
54,551
+22,349
+69% +$1.13M 0.54% 62
2013
Q4
$1.7M Hold
32,202
0.34% 91
2013
Q3
$1.44M Sell
32,202
-920
-3% -$40.8K 0.31% 92
2013
Q2
$1.37M Buy
+33,122
New +$1.45M 0.31% 92

Other funds holding ABBV

Citizens Business Bank's ABBV Position: Q1 2026 in Review

Citizens Business Bank reduced its AbbVie (ABBV) stake by 2% in Q1 2026, selling an estimated $143K and leaving 31,769 shares worth $6.91M. The position accounts for 1.13% of the portfolio, ranked #25.

Citizens Business Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.6M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Citizens Business Bank held 31,769 shares of AbbVie worth $6.91M as of Q1 2026.
  • Citizens Business Bank sold 643 AbbVie shares in Q1 2026, an estimated $143K.
  • AbbVie made up 1.13% of Citizens Business Bank's portfolio in Q1 2026, its #25 holding.
  • Citizens Business Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Citizens Business Bank's AbbVie position peaked at $10.6M in Q1 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Citizens Business Bank's 13F filing for Q1 2026, filed 1 May 2026.